X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype
- PMID: 16417886
- DOI: 10.1177/08830738050200101601
X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype
Abstract
We report a family with X-linked mental retardation that has a novel mutation in the monocarboxylate transporter 8 (MCT8) gene associated with a characteristic neurodevelopmental phenotype with early childhood hypotonia that progresses to spasticity and global developmental delays. Affected patients experience moderate to severe psychomotor delays and congenital hypotonia, develop a myopathic facies, have diminished muscle bulk and generalized muscle weakness, develop progressive spasticity and movement disorders, and have limited speech but alert, affable personalities. Acquired microcephaly and abnormal myelination on brain magnetic resonance imaging can be present. Normal monocarboxylate transporter 8 gene functioning appears to be necessary for normal thyroid-associated metabolism in neurons. Abnormal thyroid function tests appear to be a consistent finding in the absence of typical signs of thyroid dysfunction. Although the phenotype appears to be consistent, and although the neurotoxic effects of abnormal central and peripheral neuromuscular system thyroid metabolism might be partly or wholly responsible for the neurologic phenotype reported, the exact mechanism remains unclear.
Similar articles
-
The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.Best Pract Res Clin Endocrinol Metab. 2007 Jun;21(2):307-21. doi: 10.1016/j.beem.2007.03.009. Best Pract Res Clin Endocrinol Metab. 2007. PMID: 17574010 Free PMC article. Review.
-
Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.Horm Res Paediatr. 2014;82(4):261-71. doi: 10.1159/000365191. Epub 2014 Sep 18. Horm Res Paediatr. 2014. PMID: 25247785
-
Severe neurological abnormalities in a young boy with impaired thyroid hormone sensitivity due to a novel mutation in the MCT8 gene.Hormones (Athens). 2017 Apr;16(2):194-199. doi: 10.14310/horm.2002.1733. Hormones (Athens). 2017. PMID: 28742507
-
Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations.Dev Med Child Neurol. 2019 Dec;61(12):1439-1447. doi: 10.1111/dmcn.14332. Epub 2019 Aug 13. Dev Med Child Neurol. 2019. PMID: 31410843
-
[MCT8-specific thyroid hormone cell transporter deficiency: a case report and review of the literature].Rev Neurol. 2013 Jun 16;56(12):615-22. Rev Neurol. 2013. PMID: 23744248 Review. Spanish.
Cited by
-
The syndromes of reduced sensitivity to thyroid hormone.Biochim Biophys Acta. 2013 Jul;1830(7):3987-4003. doi: 10.1016/j.bbagen.2012.08.005. Epub 2012 Aug 16. Biochim Biophys Acta. 2013. PMID: 22986150 Free PMC article. Review.
-
Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain.Thyroid. 2018 Sep;28(9):1211-1220. doi: 10.1089/thy.2018.0008. Epub 2018 Jun 29. Thyroid. 2018. PMID: 29845892 Free PMC article.
-
Increased oxidative metabolism and neurotransmitter cycling in the brain of mice lacking the thyroid hormone transporter SLC16A2 (MCT8).PLoS One. 2013 Oct 1;8(10):e74621. doi: 10.1371/journal.pone.0074621. eCollection 2013. PLoS One. 2013. PMID: 24098341 Free PMC article.
-
The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.Best Pract Res Clin Endocrinol Metab. 2007 Jun;21(2):307-21. doi: 10.1016/j.beem.2007.03.009. Best Pract Res Clin Endocrinol Metab. 2007. PMID: 17574010 Free PMC article. Review.
-
Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.PLoS One. 2015 Oct 1;10(10):e0139343. doi: 10.1371/journal.pone.0139343. eCollection 2015. PLoS One. 2015. PMID: 26426690 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical